Original Research
Published on 04 May 2026
Thymidine kinase as a biomarker of chemoresistance in epithelial ovarian cancer using the KELIM model
in Pharmacology of Anti-Cancer Drugs
- 208 views
Original Research
Published on 04 May 2026
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 04 May 2026
in Biomechanics and Control of Human Movement
Original Research
Published on 04 May 2026
in Food Microbiology
Case Report
Published on 04 May 2026
in Motor Neuroscience
Original Research
Published on 04 May 2026
in Mucosal Immunity
Mini Review
Published on 04 May 2026
in Visual Neuroscience
Review
Published on 04 May 2026
in Environmental Health and Exposome
Case Report
Published on 04 May 2026
in Pediatric Surgery
Original Research
Published on 04 May 2026
in Plant Metabolism and Chemodiversity
Original Research
Published on 04 May 2026
in Nutrition and Metabolism
Review
Published on 04 May 2026
in Cognition
Review
Published on 04 May 2026
in Scholarly Communication
Original Research
Published on 04 May 2026
in Autism
Original Research
Published on 04 May 2026
in Quality of Life
Case Report
Published on 04 May 2026
in Drug, Venom & Anaphylaxis
Original Research
Published on 04 May 2026
in Environmental Health and Exposome